best performing mid cap stocks june 2022

Amylyx Pharmaceuticals (AMLX) had the highest return in June 2022 by a mid-cap US stock, returning 114.2%.

ASSETMONTH% RETURN
Amylyx Pharmaceuticals (AMLX)
June 2022
114.24%
Belite Bio Inc ADR (BLTE)
June 2022
105.54%
Cogent Biosciences (COGT)
June 2022
95.66%
Iovance Biotherapeutics (IOVA)
June 2022
66.02%
New Oriental Education & Technology (EDU)
June 2022
55.42%
Axsome Therapeutics (AXSM)
June 2022
51.68%
Miniso Group Holding  (MNSO)
June 2022
42.73%
Dyne Therapeutics  (DYN)
June 2022
42.24%
Chewy (CHWY)
June 2022
39.49%
Abcellera Biologics  (ABCL)
June 2022
38.49%
Celcuity LLC (CELC)
June 2022
36.84%
PTC Therapeutics (PTCT)
June 2022
36.35%
Gitlab (GTLB)
June 2022
34.4%
Xpeng (XPEV)
June 2022
34.21%
Full Truck Alliance Co Ltd ADR (YMM)
June 2022
33.63%
Kanzhun Ltd ADR (BZ)
June 2022
33.54%
Disc Medicine (IRON)
June 2022
33.07%
Recursion Pharmaceuticals (RXRX)
June 2022
32.79%
Arcus Biosciences (RCUS)
June 2022
32.12%
Kymera Therapeutics (KYMR)
June 2022
30.14%
Pharvaris (PHVS)
June 2022
29.66%
Viking Therapeutics (VKTX)
June 2022
28.44%
Legend Biotech  (LEGN)
June 2022
27.94%
Edgewise Therapeutics (EWTX)
June 2022
27.36%
Garrett Motion (GTX)
June 2022
26.93%
Mid-cap stocks are treated as having a market cap between $2B and $10B.

Related Searches